221 related articles for article (PubMed ID: 32062679)
21. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
22. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
Nemeth Z; Farkas N; Farkas B
Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
[TBL] [Abstract][Full Text] [Related]
23. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
[TBL] [Abstract][Full Text] [Related]
24. Vaginal pessary treatment in women with symptomatic pelvic organ prolapse: a long-term prospective study.
Ma C; Zhou Y; Kang J; Zhang Y; Ma Y; Wang Y; Tian W; Xu T; Liang S; Fan G; Cui Y; Zhu L
Menopause; 2021 Feb; 28(5):538-545. PubMed ID: 33625108
[TBL] [Abstract][Full Text] [Related]
25. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
[TBL] [Abstract][Full Text] [Related]
26. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.
Mendes LC; Bezerra LRPS; Bilhar APM; Neto JAV; Vasconcelos CTM; Saboia DM; Karbage SAL
Int Urogynecol J; 2021 Apr; 32(4):1023-1029. PubMed ID: 33048180
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
[No Abstract] [Full Text] [Related]
28. Vaginal pessaries for pelvic organ prolapse and urinary incontinence: a multiprofessional survey of practice.
Bugge C; Hagen S; Thakar R
Int Urogynecol J; 2013 Jun; 24(6):1017-24. PubMed ID: 23179500
[TBL] [Abstract][Full Text] [Related]
29. Pessary fitting for pelvic organ prolapse: parameters associated with specific reasons for failure.
Manzini C; van der Vaart CH; van den Noort F; Grob ATM; Withagen MIJ
Int Urogynecol J; 2022 Jul; 33(7):2037-2046. PubMed ID: 35066658
[TBL] [Abstract][Full Text] [Related]
30. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
[TBL] [Abstract][Full Text] [Related]
31. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
Yang J; Han J; Zhu F; Wang Y
Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
[TBL] [Abstract][Full Text] [Related]
32. Cross sectional study on assessment of ring pessary cleaning and removal every six months: adverse events and complications.
de Albuquerque Coelho SC; Pereira GMV; Brito LGO; Juliato CRT
Int Urogynecol J; 2022 Feb; 33(2):397-403. PubMed ID: 33830303
[TBL] [Abstract][Full Text] [Related]
33. Predictors for unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: a prospective study.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
BJOG; 2018 Oct; 125(11):1434-1440. PubMed ID: 29700950
[TBL] [Abstract][Full Text] [Related]
34. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
Xu H; Wu W; Wang X; Xia Z
Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
[TBL] [Abstract][Full Text] [Related]
35. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.
Wolff B; Williams K; Winkler A; Lind L; Shalom D
Int Urogynecol J; 2017 Jul; 28(7):993-997. PubMed ID: 27942793
[TBL] [Abstract][Full Text] [Related]
36. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study.
Thys S; Hakvoort R; Milani A; Roovers JP; Vollebregt A
Int Urogynecol J; 2021 Aug; 32(8):2159-2167. PubMed ID: 34002267
[TBL] [Abstract][Full Text] [Related]
37. Location and motion of vaginal pessaries in situ in women with successful and unsuccessful pessary treatment for pelvic organ prolapse.
Boogaard LL; Triepels CPR; Verhamme LM; van Kuijk SMJ; Donners JJAE; Kluivers KB; Maal TJJ; Weemhoff M; Notten KJB
Int Urogynecol J; 2023 Sep; 34(9):2293-2300. PubMed ID: 37119269
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with unsuccessful pessary fitting and reasons for discontinuation in Korean women with pelvic organ prolapse.
Oh S; Namkung HR; Yoon HY; Lee SY; Jeon MJ
Obstet Gynecol Sci; 2022 Jan; 65(1):94-99. PubMed ID: 34897264
[TBL] [Abstract][Full Text] [Related]
39. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
40. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
Ramsay S; Tu le M; Tannenbaum C
Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
